Infectious antibodies in systemic lupus erythematosus patients

Infections can act as environmental triggers that induce or promote systemic lupus erythematosus (SLE) in genetically predisposed individuals. New technologies, developed recently, enable simultaneous assessment of multiple antibodies. Antibodies to specific infectious agents may shed light into the...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2009
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/26035
Acceso en línea:
https://doi.org/10.1177/0961203309345729
https://repository.urosario.edu.co/handle/10336/26035
Palabra clave:
Systemic lupus erythematosus
Infections
Toxoplasma gondii
Rubella
Cytomegalovirus
Epstein Barr virus
Hepatitis B
Hepatitis C
Herpes simplex
Treponema pallidum
Antibodies
SLE
Rights
License
Restringido (Acceso a grupos específicos)
id EDOCUR2_b853e7691189ed19508e267fd5eec1e6
oai_identifier_str oai:repository.urosario.edu.co:10336/26035
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling ae780f69-0f13-4099-a941-822af755ad5de0c37cbb-914c-49d3-9588-2a00fa197fe16d20c285-9d8e-4321-9514-05d9dd6d04ed9312e239-92f3-4537-8074-e622330dcd2c9b47b011-2a68-42a2-b9f5-81df56106243490e3fb2-7813-48c2-b195-83a2619672888e6c26dd-7c93-449b-a6e6-fbae80578a2f194747786006b286b69-16c0-4eae-a12c-57f7a4b4c7592020-08-06T16:20:30Z2020-08-06T16:20:30Z2009-10-30Infections can act as environmental triggers that induce or promote systemic lupus erythematosus (SLE) in genetically predisposed individuals. New technologies, developed recently, enable simultaneous assessment of multiple antibodies. Antibodies to specific infectious agents may shed light into the mechanisms of induction of SLE. The aim of this study was to investigate the prevalence of seropositivity and the titers of antibodies to bacterial, viral, and parasitic agents in SLE patients compared with non-autoimmune controls. Sera from 260 individuals (120 SLE patients and 140 controls) were tested by the BioPlex 2200 Multiplexed Immunoassay method (BioRad) for the prevalence and titers of antibodies to eight infectious agents (Epstein—Barr virus: early antigen IgG, nuclear antigen IgG, viral capsid antigen IgG and IgM, heterophile IgM; cytomegalovirus IgG and IgM; Toxoplasma gondii IgG and IgM; rubella IgG and IgM; Treponema pallidum TPr15G, TPr17G, TPr47G; herpes simplex virus type 1 and 2 IgG; hepatitis C virus and hepatitis B core antibodies. Cytomegalovirus IgM and Epstein—Barr virus early antigen IgG (but not other Epstein—Barr virus antigens) were significantly more prevalent in SLE patients than in controls. Conversely, positive titers of hepatitis B core and rubella IgG antibodies were less prevalent in the SLE patients than in controls. Other differences in titer positivity prevalence were not detected between patients and controls. The titers of the cytomegalovirus IgM, Toxoplasma IgG, Epstein—Barr virus early antigen, and viral capsid antigen IgG antibodies were significantly higher in SLE compared with controls. Our data suggest the importance of previous exposure to infectious agents in the induction and the prevention of SLE. Lupus (2009) 18, 1129—1135.application/pdfhttps://doi.org/10.1177/0961203309345729ISSN: 0961-2033EISSN: 1477-0962https://repository.urosario.edu.co/handle/10336/26035engSage Publishing1135No. 131129LupusVol. 18Lupus, ISSN: 0961-2033 ; EISSN: 1477-0962, Vol.18, No.13 (2009); pp.1129-1135https://journals.sagepub.com/doi/10.1177/0961203309345729Restringido (Acceso a grupos específicos)http://purl.org/coar/access_right/c_16ecLupusinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURSystemic lupus erythematosusInfectionsToxoplasma gondiiRubellaCytomegalovirusEpstein Barr virusHepatitis BHepatitis CHerpes simplexTreponema pallidumAntibodiesSLEInfectious antibodies in systemic lupus erythematosus patientsAnticuerpos infecciosos en pacientes con lupus eritematoso sistémicoarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Berkun, Y.Zandman-Goddard, G.Barzilai, O.Boaz, M.Sherer, Y.Larida, B.Blank, M.Anaya, Juan-ManuelShoenfeld, Y.10336/26035oai:repository.urosario.edu.co:10336/260352022-05-02 07:37:13.143754https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Infectious antibodies in systemic lupus erythematosus patients
dc.title.TranslatedTitle.spa.fl_str_mv Anticuerpos infecciosos en pacientes con lupus eritematoso sistémico
title Infectious antibodies in systemic lupus erythematosus patients
spellingShingle Infectious antibodies in systemic lupus erythematosus patients
Systemic lupus erythematosus
Infections
Toxoplasma gondii
Rubella
Cytomegalovirus
Epstein Barr virus
Hepatitis B
Hepatitis C
Herpes simplex
Treponema pallidum
Antibodies
SLE
title_short Infectious antibodies in systemic lupus erythematosus patients
title_full Infectious antibodies in systemic lupus erythematosus patients
title_fullStr Infectious antibodies in systemic lupus erythematosus patients
title_full_unstemmed Infectious antibodies in systemic lupus erythematosus patients
title_sort Infectious antibodies in systemic lupus erythematosus patients
dc.subject.keyword.spa.fl_str_mv Systemic lupus erythematosus
Infections
Toxoplasma gondii
Rubella
Cytomegalovirus
Epstein Barr virus
Hepatitis B
Hepatitis C
Herpes simplex
Treponema pallidum
Antibodies
SLE
topic Systemic lupus erythematosus
Infections
Toxoplasma gondii
Rubella
Cytomegalovirus
Epstein Barr virus
Hepatitis B
Hepatitis C
Herpes simplex
Treponema pallidum
Antibodies
SLE
description Infections can act as environmental triggers that induce or promote systemic lupus erythematosus (SLE) in genetically predisposed individuals. New technologies, developed recently, enable simultaneous assessment of multiple antibodies. Antibodies to specific infectious agents may shed light into the mechanisms of induction of SLE. The aim of this study was to investigate the prevalence of seropositivity and the titers of antibodies to bacterial, viral, and parasitic agents in SLE patients compared with non-autoimmune controls. Sera from 260 individuals (120 SLE patients and 140 controls) were tested by the BioPlex 2200 Multiplexed Immunoassay method (BioRad) for the prevalence and titers of antibodies to eight infectious agents (Epstein—Barr virus: early antigen IgG, nuclear antigen IgG, viral capsid antigen IgG and IgM, heterophile IgM; cytomegalovirus IgG and IgM; Toxoplasma gondii IgG and IgM; rubella IgG and IgM; Treponema pallidum TPr15G, TPr17G, TPr47G; herpes simplex virus type 1 and 2 IgG; hepatitis C virus and hepatitis B core antibodies. Cytomegalovirus IgM and Epstein—Barr virus early antigen IgG (but not other Epstein—Barr virus antigens) were significantly more prevalent in SLE patients than in controls. Conversely, positive titers of hepatitis B core and rubella IgG antibodies were less prevalent in the SLE patients than in controls. Other differences in titer positivity prevalence were not detected between patients and controls. The titers of the cytomegalovirus IgM, Toxoplasma IgG, Epstein—Barr virus early antigen, and viral capsid antigen IgG antibodies were significantly higher in SLE compared with controls. Our data suggest the importance of previous exposure to infectious agents in the induction and the prevention of SLE. Lupus (2009) 18, 1129—1135.
publishDate 2009
dc.date.created.spa.fl_str_mv 2009-10-30
dc.date.accessioned.none.fl_str_mv 2020-08-06T16:20:30Z
dc.date.available.none.fl_str_mv 2020-08-06T16:20:30Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1177/0961203309345729
dc.identifier.issn.none.fl_str_mv ISSN: 0961-2033
EISSN: 1477-0962
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/26035
url https://doi.org/10.1177/0961203309345729
https://repository.urosario.edu.co/handle/10336/26035
identifier_str_mv ISSN: 0961-2033
EISSN: 1477-0962
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 1135
dc.relation.citationIssue.none.fl_str_mv No. 13
dc.relation.citationStartPage.none.fl_str_mv 1129
dc.relation.citationTitle.none.fl_str_mv Lupus
dc.relation.citationVolume.none.fl_str_mv Vol. 18
dc.relation.ispartof.spa.fl_str_mv Lupus, ISSN: 0961-2033 ; EISSN: 1477-0962, Vol.18, No.13 (2009); pp.1129-1135
dc.relation.uri.spa.fl_str_mv https://journals.sagepub.com/doi/10.1177/0961203309345729
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_16ec
dc.rights.acceso.spa.fl_str_mv Restringido (Acceso a grupos específicos)
rights_invalid_str_mv Restringido (Acceso a grupos específicos)
http://purl.org/coar/access_right/c_16ec
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Sage Publishing
dc.source.spa.fl_str_mv Lupus
institution Universidad del Rosario
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1808391073644412928